When I was told I had stage four prostate cancer, my life fell apart. I was told it was inoperable, incurable and terminal, and was given months to live.
I needed a second opinion, so I saw Professor Lisa Horvath at Chris O’Brien Lifehouse. She told me, “You’re only early stage four. I think I can give you some more time.” Just those words meant everything to me. They meant hope.
Professor Horvarth put me on a chemotherapy drug called docetaxel. The side effects were horrific – swollen fingers and feet, nausea, aches and pains – but it worked. My tumours shrunk.
The weariness and pain caused by the treatment surfaces regularly as a reminder. But I am incredibly thankful for the precious extra time I have been given to spend with my wife and family.
My experience with cancer has taught me two things; that the only thing worth worrying about in the world is love, and that you must live for now and help others to do the same. I relish every single moment and the opportunity I have now to help others in my situation.
Many people aren’t as fortunate. Docetaxel can ravage the body only to have no effect on the tumour. Professor Lisa Horvath and her team now have the resources to continue her vital clinical trial to identify whether Docetaxel will work on an individual’s tumour before treatment.
To those that very generously gave to our appeal in the last financial year, thank you so much for your help. On behalf of Professor Horvath, myself, and all those living with prostate cancer, thank you for enabling this research – you are helping change the face of prostate cancer.